| DNA sequencing to detect residual disease in adults with acute myeloid leukemia prior to hematopoietic cell transplant LW Dillon, G Gui, KM Page, N Ravindra, ZC Wong, G Andrew, ... Jama 329 (9), 745-755, 2023 | 59 | 2023 |
| Central nervous system actinomycosis—a clinicoradiologic and histopathologic analysis N Ravindra, N Sadashiva, A Mahadevan, DI Bhat, J Saini World Neurosurgery 116, e362-e370, 2018 | 26 | 2018 |
| JAK2 exon 12 mutations in cases with JAK2V617F-negative polycythemia vera and primary myelofibrosis M Maddali, UP Kulkarni, N Ravindra, E Jajodia, AK Arunachalam, ... Annals of hematology 99, 983-989, 2020 | 21 | 2020 |
| Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in … CS Hourigan, LW Dillon, G Gui, N Ravindra, Z Wong, G Andrew, ... Journal of Clinical Oncology 40 (16_suppl), 7006-7006, 2022 | 8 | 2022 |
| Mutation profile in BCR-ABL1-negative myeloproliferative neoplasms: A single-center experience from India M Maddali, UP Kulkarni, N Ravindra, AK Arunachalam, A Venkatraman, ... Hematology/oncology and stem cell therapy, 2021 | 7 | 2021 |
| Novel frameshift variant (c. 409dupG) in SLC25A38 is a common cause of congenital sideroblastic anaemia in the Indian subcontinent N Ravindra, R Athiyarath, S Eswari, S Sumithra, U Kulkarni, NA Fouzia, ... Journal of Clinical Pathology 74 (3), 157-162, 2021 | 5 | 2021 |
| BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal … ESB Benjamin, N Ravindra, BM Rajamani, S Anandan, B Kausalya, ... Leukemia & lymphoma 62 (6), 1528-1531, 2021 | 4 | 2021 |
| Pre-and Post-Transplant Measurable Residual IDH Mutations Are Not Associated with Relapse in Patients with IDH-Mutated AML N Ravindra, LW Dillon, G Gui, CS Hourigan, AJ Ambinder Blood 140 (Supplement 1), 3391-3392, 2022 | 3 | 2022 |
| Measurable Residual FLT3-ITD before Allogeneic Transplant for Acute Myeloid Leukemia LW Dillon, G Gui, N Ravindra, G Andrew, D Mukherjee, Z Wong, Y Huang, ... Blood 142, 4325, 2023 | 2 | 2023 |
| Measurable Residual IDH2 before Allogeneic Transplant for Acute Myeloid Leukemia G Gui, LW Dillon, N Ravindra, PS Hegde, G Andrew, D Mukherjee, ... Blood 142, 424, 2023 | 2 | 2023 |
| Pre-MEASURE: FLT3-ITD and mutated NPM1 measurable residual disease before allogeneic transplant in adults with AML in first remission LW Dillon, G Gui, N Ravindra, Z Wong, G Andrew, D Mukherjee, SL Zeger, ... medRxiv, 2022.10. 21.22281322, 2022 | 2 | 2022 |
| Maternal embryonal leucine zipper kinase immunoreactivity in atypical teratoid/rhabdoid tumors: a study of 50 cases N Ravindra, S Rao, A Arivazhagan, V Santosh Child's Nervous System 37, 3769-3775, 2021 | 2 | 2021 |
| Anaplastic ependymoma with ganglionic differentiation: report of a rare case and implications in diagnosis S Rao, N Ravindra, N Sadashiva, B Indira Devi, V Santosh International Journal of Surgical Pathology 25 (7), 644-647, 2017 | 2 | 2017 |
| Angioglioma of the spinal cord KC Joshi, K Khanapure, N Hegde, N Ravindra, AT Jagannatha, ... World Neurosurgery 96, 610. e5-610. e8, 2016 | 2 | 2016 |
| Persistence of FLT3-TKD in Blood Prior to Allogeneic Transplant Is Associated with Increased Relapse and Death in Adults with AML in First Remission PS Hegde, G Andrew, G Gui, N Ravindra, D Mukherjee, Z Wong, ... Blood 142, 2941, 2023 | 1 | 2023 |
| Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia G Gui, LW Dillon, N Ravindra, PS Hegde, G Andrew, D Mukherjee, ... Blood 142, 4316, 2023 | 1 | 2023 |
| Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia LW Dillon, G Gui, N Ravindra, G Andrew, D Mukherjee, ZC Wong, ... JAMA oncology, 2024 | | 2024 |
| Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic … N Ravindra, LW Dillon, G Gui, M Smith, LP Gondek, RJ Jones, A Corner, ... Bone marrow transplantation, 1-3, 2024 | | 2024 |
| Whole-Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia N Ravindra, C Hourigan, L Dillon, J Lack, C Dalgard, E vanCollenburg, ... JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S36-S36, 2023 | | 2023 |
| Evaluation of Molecular Methodologies for DNA-Based Measurable Residual Disease Detection in Acute Myeloid Leukemia L Dillon, N Ravindra, G Andrew, G Gui, C Hourigan JOURNAL OF MOLECULAR DIAGNOSTICS 24 (10), S31-S32, 2022 | | 2022 |
